Literature DB >> 34496421

The endoscopic ultrasound features of pancreatic fluid collections and their impact on therapeutic decisions: an interobserver agreement study.

Carlo Fabbri1, Todd H Baron2, Giulia Gibiino1, Paolo Giorgio Arcidiacono3, Cecilia Binda1, Andrea Anderloni4, Gianenrico Rizzatti5,6, Manuel Pérez-Miranda7, Andrea Lisotti8, Loredana Correale5, Joan B Gornals9, Ilaria Tarantino10, Maria Chiara Petrone3, Paolo Cecinato11, Pietro Fusaroli8, Alberto Larghi5,6.   

Abstract

BACKGROUND: A validated classification of endoscopic ultrasound (EUS) morphological characteristics and consequent therapeutic intervention(s) in pancreatic and peripancreatic fluid collections (PFCs) is lacking. We performed an interobserver agreement study among expert endosonographers assessing EUS-related PFC features and the therapeutic approaches used.
METHODS: 50 EUS videos of PFCs were independently reviewed by 12 experts and evaluated for PFC type, percentage solid component, presence of infection, recognition of and communication with the main pancreatic duct (MPD), stent choice for drainage, and direct endoscopic necrosectomy (DEN) performance and timing. The Gwet's AC1 coefficient was used to assess interobserver agreement.
RESULTS: A moderate agreement was found for lesion type (AC1, 0.59), presence of infection (AC1, 0.41), and need for DEN (AC1, 0.50), while fair or poor agreements were stated for percentage solid component (AC1, 0.15) and MPD recognition (AC1, 0.31). Substantial agreement was rated for ability to assess PFC-MPD communication (AC1, 0.69), decision between placing a plastic versus lumen-apposing metal stent (AC1, 0.62), and timing of DEN (AC1, 0.75).
CONCLUSIONS: Interobserver agreement between expert endosonographers regarding morphological features of PFCs appeared suboptimal, while decisions on therapeutic approaches seemed more homogeneous. Studies to achieve standardization of the diagnostic endosonographic criteria and therapeutic approaches to PFCs are warranted. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34496421     DOI: 10.1055/a-1640-4365

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   9.776


  1 in total

1.  Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapy.

Authors:  Louis Buscail; Adrian Culetto; Fatima-Zhora Mokhrane; Bertrand Napoléon; Olivier Meyrignac; Baptiste Molinier; Marine Lebrin; Barbara Bournet; Emilie Bérard; Cindy Canivet
Journal:  Endosc Int Open       Date:  2022-06-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.